Euroapi S.A. (LON:0EAP)

Market Cap	107.53M -47.2%
Revenue (ttm)	743.79M -7.2%
Net Income	-184.25M
EPS	-1.95
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,464
Average Volume	10,781
Open	1.291
Previous Close	1.309
Day's Range	1.289 - 1.319
52-Week Range	1.300 - 3.530
Beta	0.60
RSI	11.16
Earnings Date	Mar 3, 2026

About Euroapi

Euroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use in France, Europe, Rest of Europe, North America, the Asia Pacific, and internationally. The company offers contract development manufacturing organization for different classes of tides that uses solid phase chemistry; particle engineering; microbial fermentation; small molecules synthesis; prostaglandins; steroids and hormones; and opiates and controlled substances....

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 2020
• Employees: 3,187
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0EAP

Financial Performance

In 2025, Euroapi's revenue was 852.60 million, a decrease of -7.25% compared to the previous year's 919.20 million. Losses were -211.20 million, 61.7% more than in 2024.

Financial numbers in EUR